B. Costall

Exploration of mice in a black and white test box: Validation as a model of anxiety

B. Costall, Brian J. Jones, M.E. Kelly et al. · Pharmacology Biochemistry and Behavior · 1989 · 542 citations

Social Sciences, Behavioral Sciences, Psychology +11

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Joel W. Hughes, P. Boden, B. Costall et al. · Proceedings of the National Academy of Sciences · 1990 · 504 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Effects of the 5‐HT₃ receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

B. Costall, A.M. Domeney, R.J. Naylor et al. · British Journal of Pharmacology · 1987 · 356 citations · Full text

Medicine, Neuroscience, Pharmacology +17

The potential anxiolytic activity of GR38032F, a 5‐HT₃‐receptor antagonist

Brian J. Jones, B. Costall, A.M. Domeney et al. · British Journal of Pharmacology · 1988 · 328 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei

B. Costall, Robert J. Naylor · European Journal of Pharmacology · 1974 · 271 citations

Medicine, Neuroscience, Pharmacology +14